Evidence map›Paper›PMID 32888119›Full record

ArticleClinical & experimental metastasis2020

Correction to: Mass spectrometry-based proteomic capture of proteins bound to the MACC1 promoter in colon cancer.

Yahui Huang, Yi Xiang, Zhongpeng Xie, Yuxiang Cai, Qiongzhi Yang, Huichao Huang, Zhuchu Chen, Zhefeng Xiao, Qiongqiong He

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yahui HuangDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Yi XiangSchool of Basic Medical Sciences, Central South University, Changsha, Hunan, People's Republic of China.
Zhongpeng XieDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Yuxiang CaiDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Qiongzhi YangDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Huichao HuangNHC Key Laboratory of Cancer Proteomics, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Zhuchu ChenNHC Key Laboratory of Cancer Proteomics, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Zhefeng XiaoNHC Key Laboratory of Cancer Proteomics, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China. xiaozf@csu.edu.cn.
Qiongqiong HeDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China. qiongqionghe@csu.edu.cn.
Xiangya Hospital Central South University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication of the article, Acknowledgements section was published incorrectly. The correct Acknowledgements is given in this Correction.

Identifiers

PMID32888119
OpenAlexW3083455416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.